IL155400A0 - Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof - Google Patents

Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof

Info

Publication number
IL155400A0
IL155400A0 IL15540001A IL15540001A IL155400A0 IL 155400 A0 IL155400 A0 IL 155400A0 IL 15540001 A IL15540001 A IL 15540001A IL 15540001 A IL15540001 A IL 15540001A IL 155400 A0 IL155400 A0 IL 155400A0
Authority
IL
Israel
Prior art keywords
venlafaxine
preparing
processes
crystalline
base
Prior art date
Application number
IL15540001A
Other languages
English (en)
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27500045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL155400(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of IL155400A0 publication Critical patent/IL155400A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/10Separation; Purification; Stabilisation; Use of additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL15540001A 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof IL155400A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US24157700P 2000-10-19 2000-10-19
US25886100P 2000-12-29 2000-12-29
US27872101P 2001-03-26 2001-03-26
US29246901P 2001-05-21 2001-05-21
PCT/US2001/051017 WO2002045658A2 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof

Publications (1)

Publication Number Publication Date
IL155400A0 true IL155400A0 (en) 2003-11-23

Family

ID=27500045

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15540001A IL155400A0 (en) 2000-10-19 2001-10-19 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
IL196287A IL196287A0 (en) 2000-10-19 2008-12-31 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL196287A IL196287A0 (en) 2000-10-19 2008-12-31 Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof

Country Status (20)

Country Link
US (1) US20020143211A1 (sk)
EP (1) EP1334082A4 (sk)
JP (2) JP2004530638A (sk)
KR (1) KR20030059206A (sk)
CN (1) CN1620420A (sk)
AU (1) AU2002241764A1 (sk)
CA (1) CA2426158A1 (sk)
CZ (1) CZ20031298A3 (sk)
DE (1) DE01988460T1 (sk)
ES (1) ES2206082T1 (sk)
HR (1) HRP20030392A2 (sk)
HU (1) HUP0303496A3 (sk)
IL (2) IL155400A0 (sk)
IS (1) IS6789A (sk)
MX (1) MXPA03003459A (sk)
NO (1) NO20031743L (sk)
PL (1) PL365895A1 (sk)
SK (1) SK5762003A3 (sk)
WO (1) WO2002045658A2 (sk)
YU (1) YU30203A (sk)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en) * 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
HUP0104872A3 (en) * 2001-11-13 2004-04-28 Egis Gyogyszergyar Nyilvanosan New polymorphic forms of venlafaxine, process for their preparation, pharmaceutical compositions containing them and their use
UA77234C2 (en) * 2001-12-05 2006-11-15 Wyeth Corp Monohydrate of venlafaxine hydrochloride and methods for its preparation (variants)
MXPA04005305A (es) * 2001-12-05 2004-09-13 Wyeth Corp Nuevo polimorfo cristalino de clorhidrato de venlafaxina y metodos para preparacion del mismo.
WO2003050074A1 (en) * 2001-12-13 2003-06-19 Cadila Healthcare Limited Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
AR039164A1 (es) 2002-03-28 2005-02-09 Synthon Bv Sales de venlafaxina de baja solubilidad en agua
US6717015B2 (en) 2002-03-28 2004-04-06 Synthon Bv Venlafaxine besylate
AU2003226748A1 (en) * 2002-03-28 2003-10-13 Synthon B.V. Compositions of venlafaxine base
DE10359154A1 (de) * 2003-12-16 2005-07-28 Krka Tovarna Zdravil, D.D. Verfahren zur Herstellung von Venlafaxin und Venlafaxinhydrochlorid der Form I
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006043577A1 (ja) * 2004-10-20 2006-04-27 Mitsubishi Pharma Corporation フェニルエタノールアミン化合物の製造方法及びその中間体
JP2009511641A (ja) * 2005-10-19 2009-03-19 テバ ファーマシューティカル インダストリーズ リミティド 高純度1−〔2−ジメチルアミノ−(4−メトキシフェニル)エチル〕シクロヘキサノール塩酸塩の調製方法
WO2007049302A2 (en) * 2005-10-28 2007-05-03 Ind-Swift Laboratories Limited An improved process for the preparation of pure venlafaxine
EP2032521B1 (en) 2006-06-27 2009-10-28 Sandoz AG New method for salt preparation
AR062064A1 (es) * 2006-07-14 2008-10-15 Medichem Sa Prcesos mejorados para preparar una base de venlafaxina y sus sales
CN103588653B (zh) * 2010-10-01 2015-04-22 山东绿叶制药有限公司 4-甲基苯甲酸4-[2-二甲基胺基-1-(1-羟基环己基)乙基]苯酯盐酸盐的多晶型物、制备方法及其应用
CR20160222U (es) 2013-11-15 2016-08-26 Akebia Therapeutics Inc Formas solidas de acido { [ -(3- clorofenil) -3- hidroxipiridin -2-carbonil] amino} acetico, composiciones, y usos de las mismas

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
US4611078A (en) * 1983-10-26 1986-09-09 American Home Products Corporation Substituted phenylacetonitriles
AR255595A1 (sk) 1994-07-13 2002-05-24 Gador Sa
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
US6197828B1 (en) * 1998-12-01 2001-03-06 Sepracor, Inc. Derivatives of (+)-venlafaxine and methods of preparing and using the same
US20020183553A1 (en) * 2000-10-19 2002-12-05 Ben-Zion Dolitzky Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
AU2002212340B2 (en) * 2000-10-31 2006-12-14 Sandoz Ag Crystalline forms of venlafaxine hydrochloride
WO2002046140A1 (en) * 2000-12-07 2002-06-13 Dr. Reddy's Laboratories Ltd. Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation

Also Published As

Publication number Publication date
CZ20031298A3 (cs) 2003-10-15
CA2426158A1 (en) 2002-06-13
NO20031743D0 (no) 2003-04-15
AU2002241764A1 (en) 2002-06-18
EP1334082A4 (en) 2006-02-01
HUP0303496A3 (en) 2005-08-29
SK5762003A3 (en) 2003-11-04
WO2002045658A2 (en) 2002-06-13
ES2206082T1 (es) 2004-05-16
IL196287A0 (en) 2011-08-01
HUP0303496A2 (hu) 2004-01-28
JP2004530638A (ja) 2004-10-07
EP1334082A2 (en) 2003-08-13
IS6789A (is) 2003-04-15
PL365895A1 (en) 2005-01-10
NO20031743L (no) 2003-06-18
JP2008239629A (ja) 2008-10-09
DE01988460T1 (de) 2004-04-22
KR20030059206A (ko) 2003-07-07
WO2002045658A3 (en) 2003-01-16
HRP20030392A2 (en) 2005-04-30
YU30203A (sh) 2006-08-17
US20020143211A1 (en) 2002-10-03
CN1620420A (zh) 2005-05-25
MXPA03003459A (es) 2005-04-29

Similar Documents

Publication Publication Date Title
IL196287A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride and processes for preparing thereof
EP1463711A4 (en) "NEW POLYMORPH OF SERTRALINE HYDROCHLORIDE AND COMPOSITION CONTAINING THEREOF, NEW METHODS OF PREPARING SERTRALINE HYDROCHLORIDE POLYMORPHES AND AMORPH FORM"
IL149050A0 (en) Polymorphic forms of sertraline hydrochloride
HK1067123A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and processes for their preparation
HUP0204010A3 (en) Novel sertraline hydrochloride polymorphs, processes for preparing them, compositions containing them and their use
AU1234002A (en) Crystalline forms of venlafaxine hydrochloride
IL162171A0 (en) Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
EP1289928A4 (en) NEW AMORPHOUS FORM OF SERTRALINE HYDROCHLORIDE
HRP20030900A2 (en) Polymorphs of fexofenadine hydrochloride
IL162255A0 (en) Novel crystalline polymorph of venlafaxine hydrochloride and methods for the preparation thereof
AU2001235970A1 (en) Novel crystalline polymorphic forms of venlafaxine hydrochloride and a process for their preparation
IL159266A (en) Crystalline forms of fexofenadine and processes for the preparation thereof
AU2002247945A1 (en) Manufacture of venlafaxine hydrochloride and crystalline polymorphs thereof
SI2181982T1 (sl) Postopek za pripravo venlafaksin hidroklorida oblike I
AU2003297640A8 (en) Polymorphic forms of dihydrochloride salts of cetirizine and processes for preparation thereof
HUP0302144A3 (en) Process of preparation of aliphatic amines
PL372137A1 (en) A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form
PL376832A1 (pl) Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
AU2003243153A8 (en) Novel crystalline polymorph form-vi of olanzapine and a process for preparation thereof
AU2002308095A1 (en) Process for preparing sertraline hydrochloride polymorphic form ii
IL161816A0 (en) Polymorphs of fexofenadine base
IL140632A0 (en) A novel process for the preparation of paroxetine and novel intermediates thereof